Latest Drug Approvals news
Dr. Richard Pazdur Appointed to Lead FDA”s Drug Division After Turbulent Year
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tezspire for Chronic Rhinosinusitis With Nasal Polyps
posted October 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
New Nonhormonal Drug Approved to Treat Menopause Symptoms
posted October 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Oral Menopausal Hormone Therapy Linked to Venous Thromboembolic Risk
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Longer Reproductive Lifespan Tied to Lower Bronchiectasis Risk in Postmenopausal Women
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research
Approved-Label Populations for New Drugs Broader Than Trial Populations